Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank83
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
33.17%
↑ 156% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-59.39%
Historical baseline
PeriodValue
202533.17%
202443.40%
2023-27.52%
2022-54.20%
2021-160.20%
2020-250.39%
20190.00%